
Agilon Health (AGL) Earnings Dates & Reports
Agilon Health (AGL) Most Recent Earnings
Report Date
Period EndingQ1 2026
Est. EPS$0.95
Actual EPS$1.80
EarningsBeat
Agilon Health (AGL) Earnings
View the latest Agilon Health (AGL) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Agilon Health (AGL)
Order type
Buy in
Order amount
Est. shares
0 shares
Agilon Health (AGL) Earnings per Share (EPS) History
Signup for full accessBrowse free
Agilon Health (AGL) Latest Earnings
The value each AGL share was expected to gain vs. the value each share gained.
Agilon Health (AGL) reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of $1.80. This exceeded analysts' expectations of $0.95 by 89.47%, marking a Beat.
For comparison, Agilon Health reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.25.
Agilon Health (AGL) Earnings History
Agilon Health (AGL) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Agilon Health’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Agilon Health (AGL) Earnings FAQs
Agilon Health (AGL) last reported earnings on May 6, 2026 for Q1 2026, posting an EPS of $1.80, which Beat the estimate of $0.95 by 89.47%.
For Q1 2026, Agilon Health (AGL) reported an EPS of $1.80, exceeding analysts' estimate of $0.95 by 89.47%.
For Q1 2026, Agilon Health (AGL) Beat expectations with an actual EPS of $1.80 vs. an estimated EPS of $0.95.
Following the last earnings report on May 6, 2026, Agilon Health (AGL)'s stock price moved — from — to —.
The next Agilon Health (AGL) earnings call is scheduled for Aug. 4, 2026, where executives will discuss financial results and outlook.